Publication
Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.
Journal Paper/Review - Oct 6, 2011
De Marchis Gian Marco, Jung Simon, Colucci Giuseppe, Meier Niklaus, Fischer Urs, Weck Anja, Mono Marie-Luise, Galimanis Aekaterini, Mattle Heinrich Paul, Schroth Gerhard, Gralla Jan, Arnold Marcel, Brekenfeld Caspar
Units
PubMed
Doi
Contact
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
Use of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke is restricted to patients with an international normalized ratio (INR) less than 1.7. However, a recent study showed increased risk of symptomatic intracranial hemorrhage after IV tPA use in patients with oral anticoagulants (OAC) even with an INR less than 1.7. The present study assessed the risk of symptomatic intracranial hemorrhage, clinical outcome, and mortality after intra-arterial therapy (IAT) in patients with and without previous use of OAC.